Posted by Jason Zweig on Mar 30, 2015 in Blog, Featured, Posts |Image credit: Genetically modified Amflora cells, BASF, flickr Creative CommonsBy Jason Zweig11:17 am ET Mar. 27, 2015In a research note out today, Credit Suisse analysts Ravi Mehrotra, Jason Kantor, Anuj Shah and Jeremiah Shepard write that biotechnology stocks are not in a bubble but “rather in a new […]
Benchmarks ended the last trading session of the week on a positive note after Fed Chair Janet Yellen said there was a possibility of a gradual hike in interest rates sometime this year. The Nasdaq was boosted by a possible deal between Intel and Altera. Gains in bio-tech stocks also helped the Nasdaq end in positive territory. However, benchmarks reported […]
Benchmarks ended the last trading session of the week on a positive note after Fed Chair Janet Yellen said there was a possibility of a gradual hike in interest rates sometime this year. The Nasdaq was boosted by a possible deal between Intel and Altera. Gains in bio-tech stocks also helped the Nasdaq end in positive territory. However, benchmarks reported […]
Stock Trading Alert: Positive Expectations As Investors Bet On ReversalBy: Paul Rejczak | Mon, Mar 30, 2015SharePrintEmailStock Trading Alert originally published on March 30, 2015, 6:30 AM:Briefly: In our opinion, no speculative positions are justified.Our intraday outlook is now neutral, and our short-term outlook is neutral:Intraday outlook (next 24 hours): neutralShort-term outlook (next 1-2 weeks): neutralMedium-term outlook (next 1-3 months): […]
Source: Ligand PharmaceuticalsHow hot is biotech these days? The top two exchange trade funds focusing on biotech stocks both more than tripled the performance of the S&P 500 index over the past 12 months. That’s pretty hot.You might be asking, however, if it’s too late to still make solid returns in this sizzling sector. Not at all. There are plenty […]
Stock Market About Ready to Crash!Stock-Markets / Financial CrashMar 29, 2015 – 06:21 PM GMTBy: Brad_GudgeonLast time, I talked about there being one more rally left and then the market would drop big. I see no change in that outlook (after looking over the Gann Cycles from last Monday, I have determined that the next top would be April 2). […]
Three months into the new year and the broad U.S. equity indices have made limited progress to the upside. The Nasdaq composite lead by the healthcare/biotech and select semiconductor sectors has risen 3.28%, while the S&P 500 is essentially flat and the DJIA has actually declined six tenths of 1 percent.If you’ve been nimble and picked the right stocks in […]
Investing.com – Investing.com — While stocks on U.S. equities markets rallied on Thursday to pare earlier losses, it wasn’t enough to halt a losing streak that extended to its fourth day.One day after the Dow Jones Industrial Average fell into negative territory for the year, stocks on the Dow fell slightly again on Thursday. The Dow appeared headed for another […]
Surveying the Fed’s handiwork during last week’s press conference, Janet Yellen noted that all was awesome except that stocks were now slightly “on the high side” of their historical range. You can say that again! In fact, you can say that any one capable of uttering such tommyrot has been totally bamboozled by Wall Street’s sell-side con artists. Yes, the […]
Related CELGIs It Closing Time At The Biotech Bar?Weekly Options Outlook: Bulls Leave Money On The Table Despite A Week-End WinCelgene backs away from development of mAb for blood cancer(Seeking Alpha)Related ILMNIs It Closing Time At The Biotech Bar?3 Niche ETFs Breaking Out3 Excellent Biotech Stocks to Buy on the Dip – Stocks in the News(Zacks)By and large, the short […]
